MedTrace Logo

Tear Concentrations and Pharmacokinetics of Azithromycin Eye Drops in Healthy Volunteers

NCT03252067 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2017-08-17

No results posted yet for this study

Summary

To evaluate azithromycin tear concentrations after one drop of azithromycin eyedrops (2.5ml/25mg) in healthy volunteers.

Conditions

  • Pharmacokinetics

Interventions

DRUG

azithromycin eyedrop

Tear samples will be collected using the strips.

Sponsors & Collaborators

  • Grand Pharmaceutical (China) Co., Ltd.

    collaborator OTHER

  • Beijing Tongren Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-02
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03252067 on ClinicalTrials.gov